NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



New tuberculosis study results reported from H. Ahmadihosseini et al



September 9th, 2008

" We studied the usefulness of (99m)-Tc-methoxyisobutylisonitrile MIBI scintigraphy for differentiation between active and inactive pulmonary tuberculosis. Thirty-six patients (aged 27-82 years, 16 males and 20 females) were included in our study," scientists in Iran report.

"Each patient was injected with 740 MBq (20 mCi) Tc-99m-MIBI and both planar and single photon emission computed tomography (SPECT) imaging were performed 15 and 60 min after injection. Twenty-four patients had active pulmonary tuberculosis (proven by sputum culture), and the remainder 12 had negative sputum culture. Semiquantitative as well as visual assessments were done on all sets of images. ...


Source: TB & Outbreaks Week (2008-09-09)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login